Striverdi Respimat - Olodaterol
Boehringer Ingelheim
Description
Long-acting selective beta2 agonist.
• Over 18 years by inhalation: 5 mcg (2 puffs), once daily.
Indications
For the maintenance treatment of COPD.
Contraindications
Advised to avoid in the case of hepatic impairment, pregnancy or breast feeding.
Preparations Available
Pressurised inhalation
Sizes Available
Pressurised inhalation
Striverdi Respimat 2.5 mcg/dose, 60 doses (refills are available)
More on: Bronchodilators , Long-acting selective beta2: agonists